Catalyst Wire Dossier Catalyst Wire Dossier

Luteinizing hormone-releasing hormone analogue

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Luteinizing hormone-releasing hormone analogue, covering 2024-08-01 to 2024-08-01. Get the full timeline:

Most recent: Clinical Trial Update: Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients [Phase 2]

See pricing